TCMBANKIN001284 |
myristoleicacid |
LMFA01030250; 9E-Tetradecenoate; myristoleic acid; Myristoleinsaure; trans-9-Tetradecenoate; (E)-tetradec-9-enoic acid; 0WAJ36526B; ZINC1531062; (9E)-9-Tetradecenoic acid; (9E)-tetradecenoic acid; trans-9-Tetradecenoic acid; 9E-tetradecenoic acid; SCHEMBL156569; SCHEMBL109271; (9E)-9-Tetradecenoic acid #; YWWVWXASSLXJHU-AATRIKPKSA-N; E-9-Tetradecenoic acid; C14:1n-5; (9E)-tetradec-9-enoic acid; AC1NSMNY; 50286-30-1; UNII-0WAJ36526B; (E)-9-Tetradecenoic acid; myristelaidate; CHEBI:131381; MolPort-003-958-761; Myristelaidic acid; AKOS032954684; (E)-tetradec-9-enoate; 9-Tetradecenoic acid, (9E)- |
C14H26O2 |
226.35 g/mol |
CCCCC=CCCCCCCCC(=O)O |
TCMBANKIN002954 |
vanillin acetate |
A842489; UJGRGFLENARMJS-UHFFFAOYSA-N; ANW-38959; ACMC-209qrl; ACETIC ACID; VANILLIN; AKOS025244005; KB-62228; TRA0058976; TC-127704; ethanoic acid; 3-methoxy-4-oxidanyl-benzaldehyde; SCHEMBL81718; acetic acid; 4-hydroxy-3-methoxybenzaldehyde |
C10H12O5 |
212.2 g/mol |
CC(=O)O.COC1=C(C=CC(=C1)C=O)O |
TCMBANKIN003220 |
coniselin |
|
C21H20O8 |
|
COC1=CC(=CC2=C1OCO2)CC(=O)OCC=CC3=CC4=C(C(=C3)OC)OCO4 |
TCMBANKIN011703 |
(e)-3-methoxy-4,5-methylenedioxy-cinnamicaldehyde |
(e)-3-methoxy-4,5-methylenedioxycinnamical-dehyde |
C11H10O4 |
|
COC1=CC(=CC2=C1OCO2)C=CC=O |
TCMBANKIN015836 |
6-methoxy-7-geranyloxycoumarin |
|
|
|
|
TCMBANKIN020936 |
conkurchine |
|
C21H32N2 |
|
CC1C2CCC3C2(CCC4C3CC=C5C4(CCC(C5)N)C)C=N1 |
TCMBANKIN022438 |
3-Butynol |
927-74-2; 4-Hydroxy-1-butyne; 2-Hydroxyethylacetylene; NSC9708; ZINC01700120; buta-1,3-diyn-1-ol; 4-01-00-02219 (Beilstein Handbook Reference); InChI=1/C4H6O/c1-2-3-4-5/h1,5H,3-4H; BRN 0773710; But-3-yn-1-ol; 3-Butyne-1-ol; 130850_ALDRICH; 3-Butyn-1-ol; WLN: Q3UU1; AI3-25453; NSC 9708; 19195_FLUKA; 1-Butyn-4-ol; 3-Butynyl alcohol; EINECS 213-161-9; C06146 |
C4H6O |
70.09 |
C#CCCO |
TCMBANKIN036901 |
myristic acid |
1-Tridecanecarboxylic acid; Myristinsaeure; CH3-[CH2]12-COOH; 70079_FLUKA; AI3-15381; LMFA01010014; CH3-[CH2]12-COO(-); NCGC00091068-02; Myristic acid-[9,10-3H]; C06424; Emery 655; myristic acid ; NSC 5028; 70082_FLUKA; C14 fatty acid; ST023797; W276405_ALDRICH; CCRIS 4724; Kortacid 1499; 3uev; TUNFSRHWOTWDNC-UHFFFAOYSA-M; Tetradecanoic acid; EINECS 250-924-5; n-Tetradecoic acid; 4-02-00-01126 (Beilstein Handbook Reference); Hydrofol acid 1495; MYR; BRN 0508624; Myristate; Myristic acid (natural); Tetradecanoate; LS-190125; Crodacid; Myristic acid (8CI); EINECS 208-875-2; Prifac 2942; Myristic acid; AIDS002505; tetradecoate; W276413_ALDRICH; FEMA No. 2764; HSDB 5686; Philacid 1400; CHEBI:28875; Edenor C 14; n-tetradecoate; 45184-05-2; myristicacid; tetradecoic acid; n-Tetradecanoic acid; M3128_SIGMA; AIDS-002505; Univol U 316S; Lead dimyristate; AC1N2PSK; NCGC00091068-01; neo-Fat 14; NSC5028; Tetradecanoic acid (9CI); Hystrene 9014; Myristic acid, pure; M4792_SIGMA; CHEBI:30807; n-Tetradecan-1-oic acid; WLN: QV13; 1-tetradecanecarboxylate; 32112-52-0; n-tetradecan-1-oate; 544-63-8 |
C14H28O2 |
228.371 |
C([H])([H])(C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(O[H])=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] |
TCMBANKIN038204 |
ferulic acid |
(E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate; caffeic acid 3-methyl ether; ferulicacid; A803063; (E)-3-(4-Hydroxy-3-methoxyphenyl)-2-propenoate; CJ-00500; ZB002373; ferulate; CHEBI:29749; (2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate; 3-Methoxy-4-hydroxy-trans-cinnamate; (E)-3-(3-methoxy-4-oxidanyl-phenyl)prop-2-enoate; Ferulic Acid; AC1NUT2L; ferulic acid |
C10H10O4 |
194.18 |
COC1=C(C=CC(=C1)C=CC(=O)O)[O-] |
TCMBANKIN038585 |
Ligustilide dimer |
|
|
|
|
TCMBANKIN058948 |
PLO |
Prestwick_859; Delta5-Pregnen-3beta-ol-20-one; C01953; Pregnenolona [INN-Spanish]; Prestwick3_000546; LMST02030088; BPBio1_000651; P9129_SIGMA; 81630_FLUKA; 3beta-Hydroxy-5-pregnene-20-one; 3beta-hydroxypregn-5-ene-20-one; Prestwick0_000546; Pregn-5-en-20-one, 3beta-hydroxy-; 5-Pregnen-3-beta-ol-20-one; Prestwick1_000546; Pregn-5-en-20-one, 3beta-hydroxy- (8CI); 3beta-Hydroxy-5-pregnen-20-one; Pregnenolone (progesterone precursor); Prestwick2_000546; Pregnenolone (JAN/INN); Spectrum5_002057; 3beta-Hydroxypregn-5-en-20-one; CMC_13393; SPBio_002512; D00143; Pregn-5-en-20-one, 3-hydroxy-, (3-beta)-; Pregnenolonum [INN-Latin]; delta5-Pregnenolone; 3beta-Hydroxy-Delta5-pregnen-20-one; BSPBio_000591; CHEBI:16581; 5-Pregnen-3beta-ol-20-one; ZINC03861150; Pregn-5-en-20-one, 3-beta-hydroxy-; 3-beta-Hydroxypregn-5-en-20-one; Pregn-5-en-3beta-ol-20-one; Delta5-Pregnene-3beta-ol-20-one; PREGNENOLONE; ST5308463; (3BETA)-3-HYDROXYPREGN-5-EN-20-ONE; 5-Pregnenolone; 17beta-[1-Ketoethyl]-Delta5-androsten-3beta-ol; EINECS 205-647-4; 1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone; 145-13-1; NSC 1616; Pregn-5-ene-3beta-ol-20-one; 116907-59-6; Pregn-5-en-20-one, 3-hydroxy-, (3beta)- |
C21H32O2 |
316.5 g/mol |
CC(=O)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C |
TCMBANKIN059447 |
isomyristicin |
|
C11H12O3 |
192.21 g/mol |
CC=CC1=CC2=C(C(=C1)OC)OCO2 |
TCMBANKIN060784 |
trans-ligustilide;Ligustilide |
|
C12H14O2 |
190.24 g/mol |
CCCC=C1C2=C(C=CCC2)C(=O)O1 |
TCMBANKIN061029 |
myristic acid |
|
C14H28O2 |
228.37 |
CCCCCCCCCCCCCC(=O)O |
TCMBANKIN061805 |
myristicin; 1,3-Benzodioxole,4-methoxy-6-(2-propenyl)-; asaricin |
4-Methoxy-6-(2-propenyl)-1,3-benzodioxole; 04PD6CT78W; BNWJOHGLIBDBOB-UHFFFAOYSA-N; 4-methoxy-6-prop-2-enyl-1,3-benzodioxole; 1,3-Benzodioxole, 4-methoxy-6-(2-propenyl)-; V0156; STK693140; Myristicin, analytical standard; ZB013050; Myristicin from parsley leaf oil, >=85% (HPLC), oil; UNII-04PD6CT78W; CCG-208543; NCGC00257726-01; Myristicin; 4-Methoxy-6-[2-propenyl]-1,3-benzodioxole; C10480; FCH920323; 6-Allyl-4-methoxy-1,3-benzodioxole; Myristicine; Benzene, 5-allyl-1-methoxy-2,3-(methylenedioxy)-; HMS2270K14; SCHEMBL68041; BRN 0166218; NCGC00091427-03!4-methoxy-6-prop-2-enyl-1,3-benzodioxole; DSSTox_RID_77884; 1,3-Benzodioxole, 4-methoxy-6-(2-propenyl)- (9CI); SBB014760; CAS-607-91-0; 607M910; SR-01000838340-3; 1-Allyl-3-methoxy-4,5-methylenedioxybenzene; M9411_SIGMA; 6-allyl-4-methoxy-1,3-benzodioxol; 1-Methoxy-2,3-methylenedioxy-5-(2-propenyl)benzene; ZERO/009047; AKOS005604763; Myristicin (6CI); MFCD00133549; Myristicin from parsley leaf oil; LS-2163; DSSTox_CID_5693; MLS001065535; MCULE-6209105333; 607-91-0; 4-methoxy-6-(prop-2-en-1-yl)-1,3-benzodioxole; CHEBI:68234; DSSTox_GSID_25693; CCRIS 6782; Tox21_200172; 5-Allyl-2,3-(methylendioxy)anisole; 4-methoxy-6-prop-2-enyl-2H-benzo[d]1,3-dioxolene; 4-Methoxy-6-(2-propenyl)-1,3-benzodioxole, 9CI; ST097616; 3-methoxy,4,5-methylenedioxy-allylbenzene; EINECS 210-146-9; 5-Allyl-1-methoxy-2,3-(methylenedioxy)-Benzene; NCGC00091427-02; MolPort-003-925-569; 4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole; CHEMBL481044; SC-21462; SMR000112534; API0025964; CTK5J3915; HSDB 3516; AC1L1HSS; AN-46392; ZINC403089; DTXSID1025693; FT-0672575; 5-19-02-00631 (Beilstein Handbook Reference); 09237_FLUKA; 5-Allyl-1-methoxy-2,3-(methylenedioxy)benzene; SR-01000838340; NCGC00091427-01; myristicin; 1-allyl-3,4-methylenedioxy-5-methoxybenzene |
C11H12O3 |
192.21 g/mol |
COC1=CC(=CC2=C1OCO2)CC=C |